Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

Enterome Bioscience S.A.. (11/12/15). "Press Release: Enterome and Gustave Roussy Enter into a Microbiome-based Collaboration to Develop Novel Immunotherapy Solutions to Treat Cancer".

Organisations Organisation Enterome S.A.
  Organisation 2 Institut Gustave Roussy (IGR)
Products Product cancer immunotherapy (immuno-oncology, I-O)
  Product 2 microbial therapy
Persons Person Belichard, Pierre (Enterome 201203 CEO)
  Person 2 Prince, Caroline (Yucatan RP 201511)
     


Team director Professor Laurence Zitvogel recently highlighted in the international journal Science the crucial role of gut microbiome in eliciting innate and adaptive immune responses beneficial for the host in relation to effective therapies against cancer (chemotherapies, immunotherapy based on immune checkpoint blockers).

Enterome’s understanding of the microbiome space and Gustave Roussy’s extensive development capabilities in the immune-oncology sphere combine to create a complementary partnership that today offers a unique opportunity to co-develop the new generation of cancer drugs.

“This partnership demonstrates the growing interest from a broad range of healthcare players in our gut microbiome-based approach which has the potential to deliver breakthrough treatment solutions for a broad range of diseases,” concludes Pierre Bélichard.


About Enterome

Enterome is pioneering the development of novel drugs and diagnostics to support personalized therapies in microbiome-related diseases such as inflammatory bowel diseases, cancer, and metabolic diseases. Enterome is also leading the development of new industry standards in gut microbiome quantitative and functional analysis. This technology leadership allows Enterome to open up the new field of therapeutic target discovery in the microbiome in order to meet significant unmet medical needs. Enterome was established in 2012 in Paris, France, to develop the discoveries made by the INRA metagenomic platform. The company has raised a total of €17.5m from leading venture capital investors (Seventure Partners, Lundbeckfond Ventures & Omnes Capital) and two strategic investors (INRA
transfer & Shire).

www.enterome.com


Enterome media contacts

Agence Yucatan (France)
Caroline Prince / Cindy Taverne
Tel : + 33 1 53 63 27 35
cprince@yucatan.fr / ctaverne@yucatan.fr

Citigate Dewe Rogerson (UK)
David Dible / Mark Swallow / Marine Perrier
Tel : + 44 (0)20 7638 9571
enterome@citigatedr.co.uk


About Gustave Roussy

Gustave Roussy is the leading Cancer Centre in Europe. It is a centre where all the skills in cancer care are focused on the patient. It comprises 3,000 professional staff who are engaged in care, research and teaching.

www.gustaveroussy.fr/en
www.gustaveroussy.fr/manifesto-cancerinnovation


Gustave Roussy contacts

Director of communication
Christine Lascombe
Tél : 01 42 11 41 75
christine.lascombe@gustaveroussy.fr

Media relations
Claire Parisel
Tél. 01 42 11 50 59
06 17 66 00 26
claire.parisel@gustaveroussy.fr

   
Record changed: 2017-04-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Enterome S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px